Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Antigen</td><td class="align_center">Antibody</td><td class="align_center">Clone</td><td class="align_center">Dilution</td><td class="align_center">Commercial product used</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Vimentin</td><td class="align_center">Monoclonal mouse<br/>Anti-vimentin</td><td class="align_center">V9</td><td class="align_center">1 : 100</td><td class="align_center">DAKO</td></tr><tr><td class="align_left">Ki67</td><td class="align_center">Monoclonal mouse<br/>Anti-human Ki67 antigens</td><td class="align_center">M1B1</td><td class="align_center">1 : 100</td><td class="align_center">DAKO</td></tr><tr><td class="align_left">CD44</td><td class="align_center">Monoclonal mouse<br/>Anti-human</td><td class="align_center">DF1485</td><td class="align_center">1 : 100</td><td class="align_center">DAKO</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Primary antibodies: characteristics and applied dilution.

Gastroenterology Research and Practice

tab1

Table 1

Table 1: Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma 